Table 1

Baseline clinical data

Control (n=158)RAFT (n=175)
n (%)*Mean (SD)n (%)*Mean (SD)
Fatigue
 BRAF-NRS Effect (0–10)152 (96.2)7.23 (1.6)156 (89.1)7.10 (1.7)
 BRAF-NRS Severity (0–10)142 (89.9)6.85 (1.57)152 (86.9)6.89 (1.57)
 BRAF-NRS Coping (0–10)†142 (89.9)4.84 (2.09)152 (86.9)5.16 (2.08)
 BRAF-MDQ impact overall (0–70)142 (89.9)40.39 (12.99)152 (86.9)40.42 (12.70)
 BRAF-MDQ Physical (0–22)142 (89.9)16.19 (3.21)152 (86.9)16.12 (3.39)
 BRAF-MDQ Emotional (0–12)142 (89.9)6.71 (3.31)152 (86.9)6.55 (3.18)
 BRAF-MDQ Cognitive (0–15)142 (89.9)7.58 (4.04)152 (86.9)7.54 (4.00)
 BRAF-MDQ Living with (0–21)142 (89.9)9.90 (5.18)152 (86.9)10.21 (5.05)
Pain NRS (0–10)142 (89.9)5.57 (2.10)152 (86.9)5.70 (2.12)
Disability MHAQ (0–3)142 (89.9)0.76 (0.51)151 (86.3)0.75 (0.53)
Quality of life AIMS VAS (0–100)141 (89.2)49.89 (20.44)152 (86.9)49.16 (22.27)
Disease activity
 Assessed—DAS28 (0.96+)145 (91.8)4.23 (1.11)147 (84.0)4.22 (1.30)
 Self-report—sPDAS2 (2.4–7.9)142 (89.9)4.36 (0.99)151 (86.3)4.44 (1.06)
Anxiety HADS (0–21)142 (89.9)8.01 (4.45)151 (86.3)7.29 (4.08)
Depression HADS (0–21)142 (89.9)6.79 (3.94)151 (86.3)7.18 (3.59)
Valued life activities (0–3)142 (89.9)1.08 (0.60)151 (86.3)1.16 (0.61)
Helplessness AHI (5-30)142 (89.9)18.98 (4.74)152 (86.9)19.03 (4.67)
Self-efficacy RASE (28-140)††142 (89.9)104.38 (11.34)151 (86.3)102.49 (11.51)
Sleep quality142 (89.9)149 (85.1)
 Very good‡5 (3.5%)9 (6.0%)
 Fairly good‡58 (40.9%)48 (32.2%)
 Fairly bad‡51 (35.9%)56 (37.6%)
 Very bad‡28 (19.7%)36 (24.2%)
  • *Percentage of total randomised (Control 158, RAFT 175).

  • †Higher score=better outcome.

  • ‡Percentage of questionnaires returned.

  • AHI, Arthritis Helplessness Index; AIMS, Arthritis Impact Measurement Scale; BRAF-MDQ, Bristol RA Fatigue Multidimensional Questionnaire; BRAF-NRS, Bristol RA Fatigue Numerical Rating Scale; HADS, Hospital Anxiety and Depression Scale; MHAQ, Modified Health Assessment Questionnaire; RASE, RA Self-Efficacy.